Although MDM2 immunostaining is useful adjunct in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes, overexpression of MDM2 has also been reported in a small number of myxofibrosarcomas[15-17]. This evidence concerns the gene MDM2 and liposarcoma.